AbbVie (ABBV) IV into FDA decision on Rinvoq
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| AbbVie (NYSE: ABBV) | Delayed: 286.70 -0.04 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $286.74 | 52 Week High | $68.12 | |||
| Open | $283.88 | 52 Week Low | $50.71 | |||
| Day High | $287.16 | P/E | 62.19 | |||
| Day Low | $283.12 | EPS | $4.61 | |||
| Volume | 1,749,968 | |||||
